New test determines risk factor for breast cancer, announces NuBasix
Breast Cancer RiskAugust 29, 2002
2002 AUG 29 - (NewsRx.com & NewsRx.net) -- Researchers have developed a urine test that measures how estrogen is transformed in the body to either promote or inhibit estrogen sensitive cancers.
This process, it turns out, can be modified by diet, either increasing or decreasing cancer development risk.
For years scientists have known estrogen can encourage the development of cancer in certain tissues like the breast. A recent study of hormone replacement therapy in women was stopped due to this determination.
Researchers at Rockefeller University have been studying why this occurs and have found that the body converts estrogen into different metabolites depending upon the individual's biochemical disposition. One metabolite encourages cancer development another tends to prevent it. Studies have shown the ratio of these two provides an important indication of risk for cancer development.
NuBasic noted that this process can be modified not by drugs but by diet. Studies have shown that consumption of soy, omega-3 oils found in fish and cruciferous vegetables, like broccoli and cabbage, all tend to improve the ratio of metabolites, thereby decreasing this risk factor.
The active ingredients in cruciferous vegetables, I3C and DIM, have been extracted and are now available in pill form. Studies show that these nutritional supplements dramatically improve the risk ratio.
NuBasix Nutritional Wellness Center is a division of MetaMetrix, Inc., a clinical laboratory with 20 years experience in specialized testing related to nutritional and metabolic analyses. This article was prepared by Women's Health Weekly editors from staff and other reports.
©Copyright 2002, Women's Health Weekly via NewsRx.com & NewsRx.net

Register for
